Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:17:28 +0200Thu, 02 May 2024 14:44:00 +0200Human medicines European public assessment report (EPAR): Volibris, ambrisentan, Date of authorisation: 20/04/2008, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/volibrisHuman medicines European public assessment report (EPAR): Volibris, ambrisentan, Date of authorisation: 20/04/2008, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/volibrisThu, 02 May 2024 14:44:00 +0200Human medicineVolibris-H-C-839-II-0026 : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500134213_en.pdfVolibris-H-C-839-II-0026 : EPAR - Assessment Report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500134213_en.pdfWed, 24 Oct 2012 02:00:00 +0200Human medicine